March 26, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq ... 24th Annual Needham Virtual Healthcare Conference Date: Monday, April 7, Chatan Charan, Ph.D. appointed as Senior Vice ...
5d
Charles Schwab Investment Management Inc. acquired a new stake in MBX Biosciences, Inc. (NYSE:MBX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 93,311 shares of the ...
3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever A number of institutional investors have recently modified their holdings of MBX. Woodline Partners ...
The live webcast can be accessed in the investors section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events. Access to the webcast replay will be available ...
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback